| Website | higventures.com |
| Phone | (305) 379-2322 |
| Employees | |
| Description | Venture Capital Firm |
H.I.G. has over $8.5 billion of capital under management through six fund vehicles: venture and growth capital, lower middle market LBO, European LBO, a debt fund, real estate and a public equity hedge fund. The firm is generally considered one of the most active and successful middle market private equity franchises, consistently ranked in the top 5% of private equity firms in terms of performance. H.I.G. has invested in and managed more than 200 companies with combined sales in excess of $8 billion.
H.I.G. has venture capital offices in Atlanta and Miami. Worldwide, H.I.G. has 200 investment professionals with additional offices in Boston, New York, San Francisco, and affiliate offices in London, Hamburg and Paris in Europe.
| Company | Date | Round | Size | Participants |
| Alder Biopharmaceuticals | 4/12 | Series D | $38M | 7 |
| CardioFocus | 2/11 | Series C | $30.6M | 9 |
| Locaid | 2/11 | Series C | $13M | 2 |
| Gemin X Pharmaceuticals | 7/08 | Series C | $38M | 13 |
| Zilker Labs | 10/07 | Series D | $10M | 3 |
| CYA Technologies | 8/07 | Series B | $3M | 2 |
| FanLib | 11/06 | Series A | $3M | 1 |
| Hispanic Media | 4/06 | Venture Round | $5M | 1 |
| EGT | 2/06 | Series C | $20.5M | 4 |
| HexaTech | 11/05 | Series A | $8.9M | 4 |
| Locaid | 11/05 | Series A | $5M | 2 |
| AGEIA Technologies | 10/05 | Series C | $27.5M | 7 |
| LVL7 Systems | 2/05 | Series C | $21M | 6 |
| Lancope | 4/04 | Series C | $12.5M | 4 |